NCT01659398已完成早期 1 期
Enhanced External Counterpulsation and Its Effects on Vascular Hemodynamics in Cognitively Impaired Patients
Patrick Moriarty, MD, FACP, FACC2 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2012年6月最近更新:
适应症
试验速览
- 阶段
- 早期 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 8
- 试验地点
- 2
- 主要终点
- Change in Cognitive Function
研究概览
简要总结
The aim of this study is to investigate whether enhanced external counterpulsation (EECP) therapy for 7 consecutive weeks will improve cerebral blood flow and possibly over time enhance or slow down breakdown of cognitive function in patients diagnosed with mild cognitive impairment (MCI).
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 85 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •An adult between 18 and 85 years of age.
- •Has been evaluated to have a CDR (Clinical Dementia Rating) Score of 0.5
- •Male or female (if female must be postmenopausal for at least 1 year, surgically sterile or using an effective form of contraception).
- •Able to speak and read English.
- •Willing to comply with study specific instructions, and complete all study procedures according to protocol.
- •Able to understand study rationale and sign informed consent.
排除标准
- •Diagnosed with glaucoma
- •History of developing adverse effects to ophthalmic dilating agents (phenylephrine or tropicamide).
- •Currently taking warfarin and dabigatran (Pradaxa).
- •History of having arrhythmias - can interfere with EECP triggering.
- •Subject has bleeding diathesis.
- •Subject has active thrombophlebitis.
- •Subject has severe lower extremity vaso-occlusive disease.
- •Subject has a documented aortic aneurysm requiring surgical repair.
- •Subject is pregnant.
- •Subject with blood pressure higher than 180/110 mmHg.
- •Subject with a heart rate more than 120 bpm.
- •Subject with high risk of complications from increased venous return.
- •Subject with clinically significant valvular disease.
- •Subjects with severe vascular disease as established by the Hachinski Ischemic Index.
- •Subjects with pacemakers and other metallic implantable devices.
结局指标
主要结局
Change in Cognitive Function
时间窗: Baseline, Week 7, 6 Month
Change in cognitive function measured using the Alzheimer's Disease Assessment Scale-cognitive sub-scale (ADAS-cog). Scale is used to determine patient's mental status. The scale has 11 parts and scores range from 0 (no impairment) to 70 (severe impairment).
次要结局
- Cholesterol composition of the blood(Baseline to week 7)
- Change in Blood Viscosity(Baseline to Week 7)
- Change in Ophthalmic blood flow (OBF)(Baseline to Week 7)
研究者
Patrick Moriarty, MD, FACP, FACC
Director, Clinical Pharmacology
University of Kansas Medical Center
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Impact of Enhanced External Counterpulsation on Vascular Hemodynamics and StatusCoronary Heart DiseaseNCT03102502Sun Yat-sen University110
Unknown
不适用
Effect of Enhanced External Counterpulsation on Lower Urinary Tract SymptomsLower Urinary Tract SymptomsNCT01815697First Affiliated Hospital, Sun Yat-Sen University120
已完成
不适用
Efficacy of Enhanced External Counterpulsation on Ventricular FunctionCoronary Heart DiseaseNCT03106116Sun Yat-sen University150
Unknown
不适用
The Value of Enhanced External Counterpulsation on Erectile DysfunctionErectile DysfunctionNCT01815593First Affiliated Hospital, Sun Yat-Sen University120
尚未招募
不适用
Protective Effect of EECP Against Negative Inflammatory Response and Organ Dysfunction After Cardiovascular SurgeryCoronary Heart Disease (CHD)Cardio-pulmonary BypassCongestive Heart Failure ChronicCardiogenic Shock AcuteNCT06728605Nanjing Medical University400